PREP
Basic information
Region (hg38): 6:105273218-105454062
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PREP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 32 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 1 | 1 |
Variants in PREP
This is a list of pathogenic ClinVar variants found in the PREP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-105278152-T-C | not specified | Uncertain significance (Nov 24, 2024) | ||
6-105278158-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
6-105278173-G-A | not specified | Uncertain significance (Apr 28, 2022) | ||
6-105278194-C-A | not specified | Uncertain significance (Oct 07, 2024) | ||
6-105278237-G-A | Benign (Jul 13, 2018) | |||
6-105278244-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
6-105278289-C-T | not specified | Uncertain significance (May 11, 2022) | ||
6-105278293-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
6-105278338-G-A | not specified | Uncertain significance (Dec 06, 2024) | ||
6-105278398-C-T | not specified | Uncertain significance (Aug 28, 2024) | ||
6-105282519-A-G | not specified | Uncertain significance (Jan 16, 2024) | ||
6-105285525-T-C | not specified | Uncertain significance (May 26, 2022) | ||
6-105288761-T-C | not specified | Uncertain significance (Oct 08, 2024) | ||
6-105288818-G-C | not specified | Uncertain significance (Sep 28, 2022) | ||
6-105288834-T-C | not specified | Uncertain significance (Nov 21, 2024) | ||
6-105288858-T-C | not specified | Uncertain significance (Feb 23, 2023) | ||
6-105323738-T-C | not specified | Uncertain significance (May 26, 2024) | ||
6-105328850-A-C | not specified | Uncertain significance (May 22, 2024) | ||
6-105328904-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
6-105328915-G-A | not specified | Uncertain significance (May 08, 2024) | ||
6-105328921-G-C | not specified | Uncertain significance (May 30, 2023) | ||
6-105328923-C-G | not specified | Uncertain significance (Oct 12, 2021) | ||
6-105328934-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
6-105328991-A-T | not specified | Uncertain significance (Jun 24, 2022) | ||
6-105329008-C-T | not specified | Uncertain significance (Sep 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PREP | protein_coding | protein_coding | ENST00000369110 | 15 | 125520 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0803 | 0.920 | 125709 | 0 | 39 | 125748 | 0.000155 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.27 | 277 | 406 | 0.683 | 0.0000220 | 4695 |
Missense in Polyphen | 47 | 123.97 | 0.37913 | 1450 | ||
Synonymous | -0.392 | 166 | 160 | 1.04 | 0.00000996 | 1294 |
Loss of Function | 4.31 | 10 | 39.1 | 0.256 | 0.00000200 | 461 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000477 | 0.000475 |
Ashkenazi Jewish | 0.000103 | 0.0000992 |
East Asian | 0.000222 | 0.000217 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000160 | 0.000158 |
Middle Eastern | 0.000222 | 0.000217 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cleaves peptide bonds on the C-terminal side of prolyl residues within peptides that are up to approximately 30 amino acids long.;
- Pathway
- Renin-angiotensin system - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.389
Intolerance Scores
- loftool
- 0.473
- rvis_EVS
- -1
- rvis_percentile_EVS
- 8.47
Haploinsufficiency Scores
- pHI
- 0.0926
- hipred
- Y
- hipred_score
- 0.786
- ghis
- 0.570
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.403
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Prep
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- proteolysis
- Cellular component
- nucleus;cytoplasm;cytosol;membrane
- Molecular function
- endopeptidase activity;serine-type endopeptidase activity;protein binding;serine-type peptidase activity;serine-type exopeptidase activity;oligopeptidase activity